Clinical Trial Update: START-J: SiTAgliptin in eldeRly Trial in Japan [NA]

View source ↗

Summary

This trial update reports the completion of a study in elderly Japanese patients with Type 2 diabetes treated with sitagliptin, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (Januvia) (sitagliptin)

Snippet

Sponsor: Japan Association for Diabetes Education and Care | Conditions: Type 2 Diabetes | NA | Status: COMPLETED | Results posted: 2017-04-14